\usepackage[a4paper,margin=1in,landscape]{geometry}
\usepackage{array}
\begin{document}
\begin{tabular}{p{6cm}p{1.5cm}p{2cm}p{2cm}|p{4cm}}
& \textbf{Relative \newline Risk} & \multicolumn{2}{c}{\textbf{Contribution to Mortality}} & \textbf{Relative \newline Contribution (\%)} \\[-1.5ex]
& & \emph{India} & \emph{England} &  \\[2ex]
Male & 1.99 & $$india_male_risk$$ & $$uk_male_risk$$ & \hspace{4ex}$$male_ratio_sign$$$$male_ratio$$ \\[0.25ex]
Diabetes (Uncontrolled) & 2.36 & $$india_diabetes_uncontr_risk$$ & $$uk_diabetes_uncontr_risk$$ & \hspace{4ex}$$diabetes_uncontr_ratio_sign$$$$diabetes_uncontr_ratio$$ \\[0.25ex]
Diabetes (Controlled) & 1.50 & $$india_diabetes_contr_risk$$ & $$uk_diabetes_contr_risk$$ & \hspace{4ex}$$diabetes_contr_ratio_sign$$$$diabetes_contr_ratio$$ \\[0.25ex]
Hypertension & 0.95 & $$india_bp_high_risk$$ & $$uk_bp_high_risk$$ & \hspace{4ex}$$bp_high_ratio_sign$$$$bp_high_ratio$$ \\[0.25ex]
Obese (class I \& II) & 1.35 & $$india_obese_1_2_risk$$ & $$uk_obese_1_2_risk$$ & \hspace{4ex}$$obese_1_2_ratio_sign$$$$obese_1_2_ratio$$ \\[0.25ex]
Obese (class III) & 2.27 & $$india_obese_3_risk$$ & $$uk_obese_3_risk$$ & \hspace{4ex}$$obese_3_ratio_sign$$$$obese_3_ratio$$\\[0.25ex]
Chronic Heart Disease & 1.27 & $$india_chronic_heart_dz_risk$$ & $$uk_chronic_heart_dz_risk$$ & \hspace{4ex}$$chronic_heart_dz_ratio_sign$$$$chronic_heart_dz_ratio$$ \\[0.25ex]
Chronic Respiratory Disease & 1.78 & $$india_chronic_resp_dz_risk$$ & $$uk_chronic_resp_dz_risk$$ & \hspace{4ex}$$chronic_resp_dz_ratio_sign$$$$chronic_resp_dz_ratio$$\\[0.25ex]
Kidney Disease & 1.72 & $$india_kidney_dz_risk$$ & $$uk_kidney_dz_risk$$ & \hspace{4ex}$$kidney_dz_ratio_sign$$$$kidney_dz_ratio$$ \\[0.25ex]
Chronic Liver Disease & 1.61 & $$india_liver_dz_risk$$ & $$uk_liver_dz_risk$$ & \hspace{4ex}$$liver_dz_ratio_sign$$$$liver_dz_ratio$$ \\[0.25ex]
Severe Asthma & 1.25 & $$india_asthma_ocs_risk$$ & $$uk_asthma_ocs_risk$$ & \hspace{4ex}$$asthma_ocs_ratio_sign$$$$asthma_ocs_ratio$$ \\[0.25ex]
Haematological Cancer & 3.52 & $$india_haem_malig_1_risk$$ & $$uk_haem_malig_1_risk$$ & \hspace{4ex}$$haem_malig_1_ratio_sign$$$$haem_malig_1_ratio$$ \\[0.25ex]
Non-haematological Cancer & 1.56 & $$india_cancer_non_haem_1_risk$$ & $$uk_cancer_non_haem_1_risk$$ & \hspace{4ex}$$cancer_non_haem_1_ratio_sign$$$$cancer_non_haem_1_ratio$$ \\[0.25ex]
Psoriasis, Rheumatoid & 1.23 & $$india_autoimmune_dz_risk$$ & $$uk_autoimmune_dz_risk$$ & \hspace{4ex}$$autoimmune_dz_ratio_sign$$$$autoimmune_dz_ratio$$ \\[0.25ex]
Other Immunosuppressive Conditions & 1.69 & $$india_immuno_other_dz_risk$$ & $$uk_immuno_other_dz_risk$$ & \hspace{4ex}$$immuno_other_dz_ratio_sign$$$$immuno_other_dz_ratio$$ \\[0.25ex]
Stroke, Dementia & 1.79 & $$india_stroke_dementia_risk$$ & $$uk_stroke_dementia_risk$$ & \hspace{4ex}$$stroke_dementia_ratio_sign$$$$stroke_dementia_ratio$$ \\[0.25ex]
Other Neurological Condition & 2.46 & $$india_neuro_other_risk$$ & $$uk_neuro_other_risk$$ & \hspace{4ex}$$neuro_other_ratio_sign$$$$neuro_other_ratio$$ \\[0.25ex]
\end{tabular}

